Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Epoprostenol sodium |
Is a |
False |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epoprostenol (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Epoprostenol 1.5mg powder and solvent for infusion vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epoprostenol adverse reaction |
Causative agent (attribute) |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to epoprostenol (finding) |
Causative agent (attribute) |
False |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epoprostenol 500micrograms infusion+diluent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prostacyclin measurement |
Component |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to epoprostenol (finding) |
Causative agent (attribute) |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Epoprostenol sodium |
Is modification of (attribute) |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing epoprostenol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only epoprostenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only epoprostenol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for infusion vial |
Has basis of strength substance (attribute) |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for infusion and/or injection vial |
Has basis of strength substance (attribute) |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Epoprostenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |